-
cancer (SCLC).
NSCLC accounts for
about 85% of all lung cancers. As a class,
NSCLCs are
relatively insensitive to chemotherapy,
compared to small-cell carcinoma...
-
distinctive nuclei with granular-looking
chromatin and no
visible nucleoli.
NSCLCs comprise a
group of
three cancer types: adenocarcinoma, squamous-cell carcinoma...
-
PDGFR Idiopathic pulmonary fibrosis (IPF) / non-small cell lung
cancer (
NSCLC) /
ovarian cancer Phase III
Afatinib Irreversible ErbB
family blocker Breast...
- 2014). "Strategic
targeting of the PI3K-NFκB axis in cisplatin-resistant
NSCLC".
Cancer Biology & Therapy. 15 (10): 1367–77. doi:10.4161/cbt.29841. PMC 4130730...
- (SCC) of the lung is a
histologic type of non-small-cell lung
carcinoma (
NSCLC). It is the
second most
prevalent type of lung
cancer after lung adenocarcinoma...
- a
breakthrough therapy for
patients with
locally advanced or
metastatic NSCLCs with an EGFR exon 20
insertion mutation. Wang, Mengzhao; Yang,
James Chih-Hsin;...
-
potential role of anti-PD-1
agents as
neoadjuvant therapy in
resectable NSCLCs is also
being investigated. As for
other lung
cancer subtypes, lung adenocarcinoma...
- for the
treatment of
pleural mesothelioma and non-small cell lung
cancer (
NSCLC). It is
available as a
generic medication. In
February 2004, the U.S. Food...
-
medication used to
treat urothelial carcinoma, non-small cell lung
cancer (
NSCLC),
small cell lung
cancer (SCLC),
hepatocellular carcinoma and
alveolar soft...
- (SCLC) and non-small cell lung
cancer (
NSCLC). This is done
because of
differing responses to treatment—
NSCLC is
comparatively less
sensitive to chemotherapy...
